prednison avmc 10mg tableta
av medical cz s.r.o., praha array - 1190 prednison - tableta - 10mg - prednison
prednison avmc 2,5mg tableta
av medical cz s.r.o., praha array - 1190 prednison - tableta - 2,5mg - prednison
prednison avmc 30mg tableta
av medical cz s.r.o., praha array - 1190 prednison - tableta - 30mg - prednison
prednison avmc 5mg tableta
av medical cz s.r.o., praha array - 1190 prednison - tableta - 5mg - prednison
rectodelt 100mg Čípek
trommsdorff gmbh & co. kg, alsdorf array - 1190 prednison - Čípek - 100mg - prednison
prednison léČiva 20mg tableta
zentiva, k.s., praha array - 1190 prednison - tableta - 20mg - prednison
prednison léČiva 5mg tableta
zentiva, k.s., praha array - 1190 prednison - tableta - 5mg - prednison
abiraterone accord
accord healthcare s.l.u. - abirateron acetátu - prostatetické novotvary - endokrinní terapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
zytiga
janssen-cilag international n.v. - abirateron acetátu - prostatetické novotvary - endokrinní terapie - zytiga je indikována spolu s prednisonem či prednisolonem pro:léčbu metastatického kastraci rezistentní rakovinou prostaty u dospělých mužů, kteří jsou asymptomatičtí nebo mírně symptomatických po selhání androgen deprivační terapie u kterých chemoterapie není dosud klinicky indicatedthe léčbě metastatického kastraci rezistentní rakovinou prostaty u dospělých mužů, jejichž onemocnění se vyvíjí, nebo po docetaxelu na bázi chemoterapie.
abiraterone mylan
mylan ireland limited - abirateron acetátu - prostatetické novotvary - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.